Furthermore, KDM1A knockdown caused tumor propagating cells to lose their capacity to initiate tumors in vivo. DNMT1 is overexpressed in GBM, resulting in a lack of cell growth regulation and higher genomic instability and leading to a poor prognosis in GBM [27]. This evidence concerns the gene DNMT1 and glioblastoma.